REAX vs. NVO
REAX (Real Brokerage Inc) and NVO (Novo Nordisk A/S) are both stocks. REAX operates in Real Estate - Services (Real Estate), while NVO operates in Drug Manufacturers - General (Healthcare). Over the past 5 years, REAX returned -2.33%/yr vs 2.48%/yr for NVO. Their 0.13 correlation means their historical movements had little consistent relationship.
Performance
REAX vs. NVO - Performance Comparison
Loading charts...
Returns By Period
In the year-to-date period, REAX achieves a -56.16% return, which is significantly lower than NVO's -4.23% return.
REAX
- 1D
- -2.44%
- 1M
- -26.27%
- 6M
- -54.80%
- YTD
- -56.16%
- 1Y
- -58.76%
- 3Y*
- -0.82%
- 5Y*
- -2.33%
- 10Y*
- —
- ALL TIME*
- -28.62%
NVO
- 1D
- -8.78%
- 1M
- -6.64%
- 6M
- -18.01%
- YTD
- -4.23%
- 1Y
- 2.25%
- 3Y*
- -14.32%
- 5Y*
- 2.48%
- 10Y*
- 7.55%
- ALL TIME*
- 14.37%
Liquidity Comparison
| Position | Avg. Volume Value (2W) | Avg. Volume Value (1M) | Avg. Volume Value (3M) |
|---|---|---|---|
| $504.41M | $480.49M | $577.88M | |
| $7.04M | $8.46M | $7.60M |
REAX vs. NVO - Yearly Performance Comparison
| 2026 (YTD) | 2025 | 2024 | 2023 | 2022 | 2021 | |
|---|---|---|---|---|---|---|
REAX Real Brokerage Inc | -56.16% | -20.65% | 187.50% | 52.38% | -71.54% | -59.05% |
NVO Novo Nordisk A/S | -4.23% | -39.22% | -15.93% | 54.84% | 22.66% | 33.38% |
Correlation
The correlation between REAX and NVO is 0.21, which is low. Their historical price movements had little consistent relationship.
| Correlation | |
|---|---|
Correlation (1Y) Focuses on recent behavior, but can change the most. | 0.21 |
Correlation (3Y) Balances recent behavior with more history. | 0.18 |
Correlation (5Y) Shows whether the relationship held over a longer period. | 0.13 |
Correlation (All Time) Calculated using the full available price history since Jun 15, 2021 | 0.13 |
Fundamentals
REAX:
$348.71M
NVO:
$209.19B
REAX:
-$0.03
NVO:
DKK 27.42
REAX:
0.17
NVO:
4.15
REAX:
5.45
NVO:
6.70
REAX:
$2.08B
NVO:
DKK 327.80B
REAX:
$173.33M
NVO:
DKK 268.30B
REAX:
-$4.17M
NVO:
DKK 181.54B
Compare stocks, funds, or ETFs
Search for stocks, ETFs, and funds for a quick comparison or use the comparison tool for more options.
Return for Risk
REAX vs. NVO — Risk / Return Rank
REAX
NVO
REAX vs. NVO - Risk-Adjusted Trends Comparison
This table presents a comparison of risk-adjusted performance metrics for Real Brokerage Inc (REAX) and Novo Nordisk A/S (NVO). Risk-adjusted metrics are performance indicators that assess an investment's returns in relation to its risk, enabling a more accurate comparison of different investment options.
Values are calculated on a 1-year rolling basis and updated daily. Risk-adjusted metrics are more stable over longer periods — use the period switch above to explore them.
| REAX | NVO | Difference | |
|---|---|---|---|
| Sharpe ratioReturn per unit of total volatility | -1.08 | ||
| Sortino ratioReturn per unit of downside risk | -2.00 | ||
| Omega ratioGain probability vs. loss probability | 0.82 | 1.06 | -0.25 |
| Calmar ratioReturn relative to maximum drawdown | -0.85 | 0.11 | -0.95 |
| Martin ratioReturn relative to average drawdown | -1.32 | 0.20 | -1.52 |
Loading charts...
Drawdowns
REAX vs. NVO - Drawdown Comparison
The maximum REAX drawdown since its inception was -89.60%, which is greater than NVO's maximum drawdown of -74.70%. Use the drawdown chart below to compare losses from any high point for REAX and NVO.
Loading charts...
Drawdown Indicators
| REAX | NVO | Difference | |
|---|---|---|---|
Max DrawdownLargest peak-to-trough decline | -89.60% | -74.70% | -14.90% |
Max Drawdown (1Y)Largest decline over 1 year | -70.45% | -43.67% | -26.78% |
Max Drawdown (3Y)Largest decline over 3 years | -76.13% | -74.70% | -1.43% |
Max Drawdown (5Y)Largest decline over 5 years | -76.13% | -74.70% | -1.43% |
Max Drawdown (10Y)Largest decline over 10 years | — | -74.70% | — |
Current DrawdownCurrent decline from peak | -84.00% | -65.79% | -18.21% |
Average DrawdownAverage peak-to-trough decline | -69.65% | -17.93% | -51.72% |
Ulcer IndexDepth and duration of drawdowns from previous peaks | 44.99% | 23.97% | +21.02% |
Volatility
REAX vs. NVO - Volatility Comparison
Real Brokerage Inc (REAX) has a higher volatility of 22.32% compared to Novo Nordisk A/S (NVO) at 12.28%. This indicates that REAX's price experiences larger fluctuations and is considered to be riskier than NVO based on this measure. The chart below showcases a comparison of their rolling one-month volatility.
Loading charts...
Volatility by Period
| REAX | NVO | Difference | |
|---|---|---|---|
Volatility (1M)Calculated over the trailing 1-month period | 22.32% | 12.28% | +10.04% |
Volatility (6M)Calculated over the trailing 6-month period | 51.53% | 36.87% | +14.66% |
Volatility (1Y)Calculated over the trailing 1-year period | 61.10% | 46.77% | +14.33% |
Volatility (5Y)Calculated over the trailing 5-year period, annualized | 63.07% | 38.76% | +24.31% |
Volatility (10Y)Calculated over the trailing 10-year period, annualized | 71.28% | 32.76% | +38.52% |
Dividends
REAX vs. NVO - Dividend Comparison
REAX has not paid dividends to shareholders, while NVO's dividend yield for the trailing twelve months is around 3.83%.
| Position | TTM | 2025 | 2024 | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
NVO Novo Nordisk A/S | 3.83% | 3.31% | 1.68% | 1.00% | 1.20% | 1.35% | 1.87% | 2.14% | 1.45% | 1.52% | 2.87% | 0.92% |
REAX Real Brokerage Inc | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% | 0.00% |
Financials
REAX vs. NVO - Financials Comparison
This section allows you to compare key financial metrics between Real Brokerage Inc and Novo Nordisk A/S. You can select fields from income statements, balance sheets, and cash flow statements to easily visualize and compare the financial health of both companies.
Total Revenue: Total amount of money received from sales and other business activities
REAX vs. NVO - Profitability Comparison
REAX - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Real Brokerage Inc reported a gross profit of 41.58M and revenue of 465.55M. Therefore, the gross margin over that period was 8.9%.
NVO - Gross Margin
Gross margin is calculated as gross profit divided by revenue. For the three months ending on Aug 2026, Novo Nordisk A/S reported a gross profit of 83.23B and revenue of 96.82B. Therefore, the gross margin over that period was 86.0%.
REAX - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Real Brokerage Inc reported an operating income of -3.13M and revenue of 465.55M, resulting in an operating margin of -0.7%.
NVO - Operating Margin
Operating margin is calculated as operating income divided by revenue. For the three months ending on Aug 2026, Novo Nordisk A/S reported an operating income of 59.62B and revenue of 96.82B, resulting in an operating margin of 61.6%.
REAX - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Real Brokerage Inc reported a net income of -3.42M and revenue of 465.55M, resulting in a net margin of -0.7%.
NVO - Net Margin
Net margin is calculated as net income divided by revenue. For the three months ending on Aug 2026, Novo Nordisk A/S reported a net income of 48.56B and revenue of 96.82B, resulting in a net margin of 50.2%.
Frequently Asked Questions
REAX and NVO have a correlation of 0.21, meaning they provide meaningful diversification benefit when combined. Depending on your allocation goals, holding both could reduce overall portfolio risk.
REAX has higher volatility (22.32%) compared to NVO (12.28%). In terms of maximum drawdown, REAX dropped -89.60% vs NVO's -74.70%.
NVO currently has the higher Sharpe Ratio (0.10 vs -0.98), meaning it's delivered slightly more return per unit of risk over the trailing 12 months. However, this ranking shifts over time - use the Risk/Return Score above for a more comprehensive view that combines Sharpe, Sortino, and other measures used by quantitative funds.
Find the right allocation for REAX and NVO
Add both to a portfolio and optimize allocations for your target — whether that's maximizing returns, minimizing drawdowns, or balancing risk across holdings.
Open Portfolio Optimizer